Overview
Actuated Medical's NeuralGlider(r) Precision Brain Access Platform has been scientifically validated by more than 40 preclinical neuroscience research groups worldwide and cited in over 44 peer-reviewed publications. Actuated is now optimizing NeuralGlider for clinical applications to improve access to deep brain targets while reducing tissue disruption in delicate brain structures. The company is partnering with organizations seeking to improve the insertion precision of neuromodulation systems, gene therapies, brain-computer interfaces, and other next-generation neurotechnologies.
More in Neurotechnology
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →